Santa Cruz Biotechnology delivers a wide array of Angptl5 monoclonal antibodies for research focused on understanding Angptl5 in various biological processes. Angptl5 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Angptl5, or angiopoietin-like 5, is a protein that plays a crucial role in lipid metabolism and energy homeostasis. Angptl5 regulates triglyceride levels and has been linked to metabolic disorders, making it a significant focus for research in obesity and cardiovascular diseases. Understanding Angptl5 function can provide insights into potential therapeutic strategies for metabolic conditions. Research has shown that Angptl5 expression patterns vary across different tissues and developmental stages. Recent studies have highlighted the importance of Angptl5 in adipose tissue development and energy expenditure. Investigating Angptl5 signaling pathways continues to reveal new connections to metabolic regulation and disease progression. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of Angptl5 and its impact on human health.